New Market Research Report: Kuwait Pharmaceuticals & Healthcare Report Q3 2013
Opportunities in Kuwait's healthcare and pharmaceuticals market are limited, given its small population, limited domestic drug production and the high proportion of expatriates. The government funds the majority of healthcare spending - around 80% - but we forecast that private spending will increase, not least due to the government's decision to raise the fees non-Kuwaiti nationals pay to use the public healthcare system. We expect that the increased income gained will be used to expand public healthcare offerings. Currently many...
View full press release